Ellenbogen Michael 4

What Happened Michael Ellenbogen, a director of Evolv Technologies Holdings, Inc. (EVLV), was granted 28,318 restricted stock units (RSUs) on June 18, 2026. The award is recorded at $0.00 per RSU (no cash paid or received) and is a derivative grant that represents the right to receive one share of Class A common stock per RSU upon vesting. This is an equity award (grant), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-18; Filing date: 2026-06-22 (filed within the standard two-business-day Form 4 window).
• Award: 28,318 RSUs; reported price: $0.00; immediate cash value: $0.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote highlights:
  • F1: Each RSU converts to one share of Class A common stock; RSUs have no expiration.
  • F2: RSUs vest in full at the earlier of June 18, 2027 or the day before the issuer's next annual meeting.
• Transaction type: A (Award/Grant) — derivative grant, not a purchase (code A).

Context RSU grants are common compensation for executives and directors and do not involve immediate cash flow; their ultimate value depends on Evolv's share price when the RSUs vest and are settled. Because this was a grant (not a sale), it typically reflects compensation or retention incentives rather than a direct signal of buying or selling intent.